# CRPPA

## Overview
CRPPA is a gene that encodes the enzyme CDP-L-ribitol pyrophosphorylase A, which plays a pivotal role in the biosynthesis of CDP-ribitol, a key precursor in the glycosylation of α-dystroglycan. This enzyme is classified as a pyrophosphorylase and is essential for the formation of ribitol phosphate structures within glycan chains, which are crucial for the proper function of the dystrophin-glycoprotein complex. The glycosylation process facilitated by CDP-L-ribitol pyrophosphorylase A is vital for the creation of the laminin-binding epitope, matriglycan, necessary for sarcolemmal stability and neural cell migration (Imae2021Biosynthetic; Kanagawa2018Ribitolphosphate—a). Mutations in the CRPPA gene can lead to congenital muscular dystrophies, highlighting its significance in maintaining muscle integrity and normal neurological development.

## Structure


## Function
CDP-L-ribitol pyrophosphorylase A (CRPPA) is an enzyme involved in the biosynthesis of CDP-ribitol, a crucial precursor in the formation of ribitol phosphate structures within glycan chains. These structures are essential for the proper glycosylation of α-dystroglycan, a component of the dystrophin-glycoprotein complex that links the extracellular matrix to the actin cytoskeleton. This glycosylation is vital for the formation of the laminin-binding epitope, matriglycan, which is necessary for sarcolemmal stability and neural cell migration (Imae2021Biosynthetic).

CRPPA catalyzes the conversion of ribitol-5-phosphate and CTP into CDP-ribitol, which is then used by other enzymes, such as fukutin and FKRP, to transfer ribitol phosphate to specific sites on the glycan structure. This process is critical for the initiation of LARGE-dependent matriglycan formation, which is essential for the laminin-binding activity of dystroglycan (Kanagawa2018Ribitolphosphate—a).

In healthy human cells, CRPPA is active in the cytoplasm, where it contributes to the normal glycosylation processes that are crucial for maintaining cellular integrity and function. Defects in this pathway can lead to congenital muscular dystrophies known as α-dystroglycanopathies (Imae2021Biosynthetic).

## Clinical Significance
Mutations in the CRPPA gene are linked to congenital muscular dystrophies, notably Walker-Warburg syndrome. This condition is characterized by a combination of muscle weakness, brain malformations, and eye abnormalities. The CRPPA gene is crucial for the synthesis of ribitol, a sugar alcohol involved in glycosylation processes. Disruptions in these processes due to CRPPA mutations can lead to the severe phenotypic manifestations observed in affected individuals. Alterations in the expression or function of CRPPA can interfere with normal cellular activities, contributing to the pathogenesis of these diseases. The impact of CRPPA mutations underscores the importance of proper glycosylation in maintaining muscle integrity and normal neurological development.


## References


[1. (Imae2021Biosynthetic) Rieko Imae, Hiroshi Manya, and Tamao Endo. Biosynthetic mechanisms and biological significance of glycerol phosphate-containing glycan in mammals. Molecules, 26(21):6675, November 2021. URL: http://dx.doi.org/10.3390/molecules26216675, doi:10.3390/molecules26216675. This article has 2 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/molecules26216675)

[2. (Kanagawa2018Ribitolphosphate—a) Motoi Kanagawa and Tatsushi Toda. Ribitol-phosphate—a newly identified posttranslational glycosylation unit in mammals: structure, modification enzymes and relationship to human diseases. The Journal of Biochemistry, 163(5):359–369, January 2018. URL: http://dx.doi.org/10.1093/jb/mvy020, doi:10.1093/jb/mvy020. This article has 20 citations.](https://doi.org/10.1093/jb/mvy020)